Nano-Based Technology in Glioblastoma.

Area of Science:

• Neuro-oncology
• Nanomedicine
• Biotechnology

Background:

• Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor.
• Current treatments (surgery, radiation, chemotherapy) face limitations due to tumor heterogeneity and the blood-brain barrier (BBB).
• The immunosuppressive tumor microenvironment further hinders therapeutic efficacy.

Purpose of the Study:

• To review the application of nanotechnology in Glioblastoma (GBM) treatment.
• To highlight nano-based strategies for overcoming therapeutic challenges in GBM.
• To emphasize the potential of multimodal approaches utilizing nanotechnology.

Main Methods:

• Literature review focusing on nanotechnology applications in Glioblastoma (GBM).
• Analysis of studies investigating nano-based drug delivery systems for brain tumors.
• Synthesis of information on overcoming the blood-brain barrier (BBB) using nanotechnologies.

Main Results:

• Nanotechnology enables targeted delivery of therapeutics across the blood-brain barrier (BBB).
• Nano-based systems can address Glioblastoma (GBM) heterogeneity and the immunosuppressive microenvironment.
• Multimodal nano-therapies show potential for enhanced treatment outcomes.

Conclusions:

• Nanotechnology presents a transformative approach for Glioblastoma (GBM) treatment.
• Nano-based strategies are crucial for improving drug delivery and overcoming biological barriers.
• The integration of nanotechnology into multimodal therapies is key to advancing Glioblastoma (GBM) management.